Not applicableWithdrawnNCT02069340
What this trial is testing
Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid
Who this might be right for
Malignant NeoplasmMusculoskeletal Complications
University of Southern California